The EU wants to strengthen EU cooperation on health technology assessment (HTA). The main purpose of HTA is to provide policy-makers with evidence-based information, so they can formulate health ...

This post is part of the Health Affairs Blog short series, “Value Assessment: Where Do We Go Post-COVID?” The series explores what we have learned about value assessment and related issues during the ...

A white paper published by the Institute for Clinical and Economic Review (ICER) established a series of recommendations and guidelines for health technology assessment that aim to address health care ...

Many researchers working on health technology assessments (HTAs) are keen to address disparities in health care. But the COVID-19 pandemic and recent prominence of the Black Lives Matter movement have ...

Value in Health, the official journal of ISPOR- the professional society for health economics and outcomes research, announced today the publication of a series of articles investigating the use of ...

Health technology assessment (HTA) is a formidable task across drug development, medical device innovation, and digital health solutions. To help with this task, the European HTA Regulation entered ...

The EU has taken a major step towards new rules which will benefit patients' access to medicinal products and medical devices and simplify the submission procedure for producers of such health ...

The University of Wyoming School of Pharmacy in the College of Health Sciences has launched a new certificate program aimed at providing practicing pharmacists, other health professionals and health ...

Today, the Center for Innovation & Value Research (the Center) released a new report highlighting actions for stakeholders to ensure health disparities and equity are being addressed in health ...

The public outcry to “do something” about health care spending keeps growing, but fear about what that might entail stymies action. Americans need affordable, accessible, and innovative health care.

While waiting for a new governance to make the process of selecting and purchasing medical devices more efficient, thus incentivizing investment in innovative technologies, the activation of the ...

The biopharma industry lauded the first steps the Australian government has taken to widen access for drugs and devices via reforms to the current health technology assessment process that has ...